| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 30,348 | 30,348 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 3,406,187 | 1,040,176 |
| AKEBIA THERAPEUTICS INC | 1,762,765 | 321,587 |
| AMERICAN WELL CORPORATION | 1,001,250 | 1,182,632 |
| ANNEXON INC | 2,466,367 | 2,905,074 |
| ASSEMBLY BIOSCIENCES INC. | 305,401 | 87,927 |
| AILERON THERAPEUTICS | 400,000 | 204,691 |
| AADI BIOSCIENCE | 1,454,921 | 640,893 |
| AADI BIOSCIENCE - CVR | 200,151 | 200,151 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| GS CAPITAL PTRS V PCP FUND | AT COST | 639,130 | 63,000 |
| GS MEZZANINE PTRS 2006 FUND | AT COST | 425,479 | 90,700 |
| GS CAPITAL PTRS VI PIA FUND | AT COST | 207,788 | 517,850 |
| GS MEZZANINE PTRS V PIA FUND | AT COST | 455,037 | 72,300 |
| GS MBD 2011 OFFSHORE LP | AT COST | 49,323 | 541,100 |
| BIOTECHNOLOGY VALUE FUND LP | AT COST | 9,537 | 2,602 |
| GREAT POINT PARTNERS I LP | AT COST | 98,686 | 165,420 |
| GREAT POINT PARTNERS II LP | AT COST | 379,907 | 933,206 |
| IREO FUND II, LTD | AT COST | 2,441,997 | 2,436,129 |
| RANE CORP | AT COST | 250,000 | 250,000 |
| RCP-OPPORTUNITIES FUND II LP | AT COST | 787,099 | 787,099 |
| REDMILE CAPITAL OS CL A SUB 7 | AT COST | 157,239 | 480,428 |
| REDMILE CAPITAL OS CL C | AT COST | 121,039 | 598,675 |
| REDWOOD OFFSHORE FUND (B) | AT COST | 4,471 | 50,346 |
| REX - REAL ESTATE EXCHANGE | AT COST | 1,014,000 | 3,463,788 |
| TPG-AXON PTRS OFFSHORE LTD | AT COST | 17,930 | 34,185 |
| TPG AP (OFFSHORE) INV FEE RES | AT COST | 5,352 | 249 |
| TSF LINQ3 BLOCKER | AT COST | 2,692,756 | 0 |
| TSF RESTORSEA BLOCKER | AT COST | 1,215,472 | 50,301 |
| CO-PILOT | AT COST | 725,000 | 725,000 |
| ANNXU INDUSTRIAL CAPITAL PARTNER | AT COST | 41,641 | 40,939 |
| GREAT POINT PARTNERS II SALMON | AT COST | 372 | 33,419 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 19,993 | 19,993 | 0 | 0 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| RECEIVABLE | 84,396 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK FEES | 1,050 | 525 | 0 | 525 |
| ADMINISTRATION FEES | 141,823 | 0 | 0 | 141,823 |
| OTHER DUES AND FEES | 450 | 450 | 0 | 0 |
| INVESTMENT MANAGEMENT FEES | 245,082 | 245,082 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| INVESTMENT INCOME FROM PARTNERSHIPS | 22,019 | 22,019 | 0 |
| OTHER INCOME | 6 | 6 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CONSULTING FEES | 195,730 | 0 | 0 | 195,730 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL EXCISE TAXES | 10,000 | 0 | 0 | 0 |